Superpharm Holdings Ltd

	Page
Abridged Balance Sheet	1
Notes to the Abridged Financial Statements	2

Registered number: 11900750

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Investments	4		1,988,900		1,988,900

			1,988,900		1,988,900
CURRENT ASSETS
Cash at bank and in hand		157		157

		157		157
NET CURRENT ASSETS (LIABILITIES)			157		157

TOTAL ASSETS LESS CURRENT LIABILITIES			1,989,057		1,989,057

Creditors: Amounts Falling Due After More Than One Year			(990,200 )		(990,200 )

NET ASSETS			998,857		998,857

CAPITAL AND RESERVES
Called up share capital	5		1,000,000		1,000,000
Profit and Loss Account			(1,143 )		(1,143 )

SHAREHOLDERS' FUNDS			998,857		998,857

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 31 March 2025 in accordance with section 444(2A) of the Companies Act 2006.

On behalf of the board

Mr Khalid Iqbal

Director

05/12/2025

The notes on page 2 form part of these financial statements.

1. General Information

Superpharm Holdings Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11900750 . The registered office is Benchill Pharmacy, 206 Holly Hedge Road, Manchester, M22 4QN.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 2 (2024: 1)

4. Investments

	Total
	£
Cost or Valuation
As at 1 April 2024	1,988,900

As at 31 March 2025	1,988,900

Provision
As at 1 April 2024	-

As at 31 March 2025	-

Net Book Value
As at 31 March 2025	1,988,900

As at 1 April 2024	1,988,900

5. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	1,000,000	1,000,000